Mankind Pharma IPO
Mankind Pharma Limited (MANKIND) · mainboard IPO on NSE and BSE · 100% Book Building. Listed on 09 May 2023.
Issue details
Listing day
Back-tested estimate (from a model that had only seen earlier years' IPOs): listing gain +8.5% (likely range -6% to +27%), day's high +16.4%, chance of a gain 82%. Actual: +20.4% at the open, +32.4% at the high.
Subscription status
| Category | Shares offered | Shares bid for | Subscribed | |
|---|---|---|---|---|
| QIB (institutions) | 80,11,769 | 39,38,34,103 | 49.2x | |
| NII (HNI) total | 60,08,827 | 2,28,22,761 | 3.80x | |
| Big NII (above ₹10 lakh) | 40,05,885 | 2,00,00,500 | 4.99x | |
| Small NII (₹2-10 lakh) | 20,02,942 | 28,22,261 | 1.41x | |
| Retail | 1,40,20,596 | 1,28,56,038 | 0.92x | |
| Total | 2,80,41,192 | 42,95,12,902 | 15.3x |
Bids on NSE and BSE together, as published by NSE, as of 27 Apr 2023, 07:00 PM. Shares offered exclude the anchor portion. 2% of all shares bid for were at the cut-off price.
Past IPOs with similar demand
Earlier mainboard IPOs whose QIB, NII and retail subscription and size were closest to Mankind Pharma's, and how they listed.
| IPO | QIB | NII | Retail | Total | Size | Listing gain | Day high |
|---|---|---|---|---|---|---|---|
| Rainbow Childrens MedicareApr 2022 | 38.9x | 3.73x | 1.38x | 12.4x | ₹1,581 Cr | -5.9% | -4.5% |
| Global HealthNov 2022 | 28.6x | 4.02x | 0.88x | 9.58x | ₹2,252 Cr | +19.4% | +26.4% |
| Bandhan BankMar 2018 | 38.7x | 13.9x | 1.20x | 14.6x | ₹4,473 Cr | +33.1% | +33.1% |
| PB FintechNov 2021 | 24.9x | 7.82x | 3.31x | 16.6x | ₹6,224 Cr | +17.4% | +27.4% |
| HDFC Standard Life Insurance CompanyNov 2017 | 16.6x | 2.29x | 0.94x | 4.90x | ₹8,695 Cr | +6.9% | +27.2% |
| Aether IndustriesMay 2022 | 17.6x | 2.52x | 1.14x | 6.26x | ₹865 Cr | +9.7% | +20.6% |
Lead managers and their listing record
| Book running lead manager | Mainboard IPOs since 2019 | Avg listing gain | Listed at a premium |
|---|---|---|---|
| Kotak Mahindra Capital Company | 83 | +20.8% | 76% |
| Axis Capital | 107 | +20.4% | 73% |
| IIFL Securities | 94 | +19.3% | 71% |
| Jefferies India | 26 | +19.5% | 81% |
| J.P. Morgan India | 27 | +17.4% | 74% |
Offer documents (NSE)
Frequently asked
What is the Mankind Pharma IPO price band and lot size? ₹1,026–1,080 per share, with a lot of 13 shares, so the smallest retail bid is ₹14,040.
How many times has it been subscribed? 15.3x overall: QIB 49.2x, NII 3.80x, retail 0.92x.
How did it list? It opened at ₹1,300, +20.4% against the issue price of ₹1,080, and closed its first day +31.7%.
